UroGen Pharma (URGN) Prepaid Assets (2016 - 2026)

UroGen Pharma (URGN) has 11 years of Prepaid Assets data on file, last reported at $19.5 million in Q1 2026.

• Quarterly Prepaid Assets rose 50.43% year-over-year to $19.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.5 million (up 50.43% YoY) and the FY2025 annual result came in at $14.7 million, up 65.88% from the prior year.
• Prepaid Assets grew to $19.5 million in Q1 2026, from $14.7 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $19.5 million in Q1 2026 to a low of $8.8 million in Q4 2024.
• A 5-year average of $12.3 million and a median of $12.1 million in 2025 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2022 — Prepaid Assets jumped 96.55% — and 2024, when it retreated 13.97%.
• Tracing URGN's Prepaid Assets over 5 years: stood at $11.1 million in 2022, then fell by 7.39% to $10.3 million in 2023, then dropped by 13.97% to $8.8 million in 2024, then surged by 65.88% to $14.7 million in 2025, then surged by 33.11% to $19.5 million in 2026.
• The last three Prepaid Assets figures came in at $19.5 million (Q1 2026), $14.7 million (Q4 2025), and $12.1 million (Q3 2025), per Business Quant data.